نتائج البحث - "Crivelli, Lucia"

العلاقة: GeroScience; 1. Abbatecola AM, Paolisso G, Lamponi M, Bandinelli S, Lauretani F, et al. Insulin resistance and executive dysfunction in older persons. Journal of the American Geriatrics Society. 2004;52:1713–8.; 2. Andreasen N, Blennow K. Beta-amyloid (Abeta) protein in cerebrospinal fuid as a biomarker for Alzheimer’s disease. Peptides. 2002;23:1205–14.; 3. Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, et al. Tau in cerebrospinal fuid: a potential diagnostic marker in Alzheimer’s disease. Ann Neurol. 1995;38:649–52.; 4. Alzheimer’s Association. Alzheimer’s disease facts and fgures. 2018. https://www.alz.org/media/HomeOfceTest/ Facts%20and%20Figures/facts-and-fgures.pdf.; 5. Bakkour A, Morris JC, Dickerson BC. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology. 2009;72:1048–55.; 6. Bharath LP, Agrawal M, McCambridge G, Nicholas DA, Hasturk H, et al. Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated infammation. Cell metabolism. 2020;32:44-55 e6.; 7. Biancardi VC, Son SJ, Ahmadi S, Filosa JA, Stern JE. Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier. Hypertension. 2014;63:572–9.; 8. Blennow K, Zetterberg H. Biomarkers for Alzheimer’s disease: current status and prospects for the future. J Intern Med. 2018;284:643–63.; 9. Criado-Marrero M, Smith TM, Gould LA, Kim S, Penny HJ, et al. FKBP5 and early life stress afect the hippocampus by an age-dependent mechanism. Brain, behavior, & immunity - health. 2020;9:100143.; 11. Chen Y, Zhao S, Fan Z, Li Z, Zhu Y, et al. Metformin attenuates plaque-associated tau pathology and reduces amyloid-beta burden in APP/PS1 mice. Alzheimer’s research & therapy. 2021;13:40.; 12. Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014;71:961–70.; 13. Duarte AI, Moreira PI, Oliveira CR. Insulin in central nervous system: more than just a peripheral hormone. Journal of aging research. 2012;2012:384017.; 14. Farr SA, Roesler E, Niehof ML, Roby DA, McKee A, Morley JE. Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer’s disease. Journal of Alzheimer’s disease : JAD. 2019;68:1699–710.; 15. Ghasemi R, Haeri A, Dargahi L, Mohamed Z, Ahmadiani A. Insulin in the brain: sources, localization and functions. Mol Neurobiol. 2013;47:145–71.; 16. Han J, Li Y, Liu X, Zhou T, Sun H, et al. Metformin suppresses retinal angiogenesis and infammation in vitro and in vivo. PloS one. 2018;13:e0193031.; 17. Ihara M, Saito S. Drug repositioning for Alzheimer’s disease: fnding hidden clues in old drugs. Journal of Alzheimer’s disease : JAD. 2020;74:1013–28.; 18. Imfeld P, Bodmer M, Jick SS, Meier CR. Metformin, other antidiabetic drugs, and risk of Alzheimer’s disease: a population-based case-control study. J Am Geriatr Soc. 2012;60:916–21.; 19. Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, et al. NIA-AA research framework: toward a biological defnition of Alzheimer’s disease. Alzheimer’s Dementia. 2018;14:535–62.; 20. Justice JN, Gubbi S, Kulkarni AS, Bartley JM, Kuchel GA, Barzilai N. A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin. GeroScience. 2021;43:1093–112.; 21. Kim D, Lee JE, Jung YJ, Lee AS, Lee S, et al. Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice. Int J Mol Med. 2013;32:1293–302.; 22. Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Infammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement (N Y). 2018;4:575–90.; 23. Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, et al. World-Wide FINGERS Network: a global approach to risk reduction and prevention of dementia. Alzheimer’s Dementia. 2020;16:1078–94.; 24. Koenig AM, Mechanic-Hamilton D, Xie SX, Combs MF, Cappola AR, et al. Efects of the insulin sensitizer metformin in Alzheimer disease: pilot data from a randomized placebo-controlled crossover study. Alzheimer Dis Assoc Disord. 2017;31:107–13.; 25. Lee S, Kang BM, Kim JH, Min J, Kim HS, et al. Real-time in vivo two-photon imaging study reveals decreased cerebro-vascular volume and increased bloodbrain barrier permeability in chronically stressed mice. Sci Rep. 2018;8:13064.; 26. Li MZ, Zheng LJ, Shen J, Li XY, Zhang Q, et al. SIRT1 facilitates amyloid beta peptide degradation by upregulating lysosome number in primary astrocytes. Neural Regen Res. 2018;13:2005–13.; 27. Liu X, Chhipa RR, Nakano I, Dasgupta B. The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent. Mol Cancer Ther. 2014;13:596–605.; 28. Lv WS, Wen JP, Li L, Sun RX, Wang J, et al. The efect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats. Brain Res. 2012;1444:11–9.; 29. Ma R, Yi B, Riker AI, Xi Y. Metformin and cancer immunity. Acta Pharmacol Sin. 2020;41:1403–9.; 30. MacVicar BA, Newman EA. Astrocyte regulation of blood fow in the brain. Cold Spring Harbor Perspect Biol 2015;7.; 31. Manaenko A, Chen H, Kammer J, Zhang JH, Tang J. Comparison Evans Blue injection routes: intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage model. J Neurosci Methods. 2011;195:206–10.; 32. Markowicz-Piasecka M, Sikora J, Szydlowska A, Skupien A, Mikiciuk-Olasik E, Huttunen KM. Metformin - a future therapy for neurodegenerative diseases: Theme: Drug Discovery, Development and Delivery in Alzheimer’s Disease Guest Editor: Davide Brambilla. Pharm Res. 2017;34:2614–27.; 33. Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, et al. Metformin improves healthspan and lifespan in mice. Nat Commun. 2013;4:2192.; 34. Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care. 2013;36:2981–7.; 35. Ng TP, Feng L, Yap KB, Lee TS, Tan CH, Winblad B. Long-term metformin usage and cognitive function among older adults with diabetes. Journal of Alzheimer’s disease : JAD. 2014;41:61–8.; 36. Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385:2255–63.; 37. Ping F, Jiang N, Li Y. Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis. BMJ Open Diabetes Res Care 2020;8.; 38. Ronaldson PT, Davis TP. Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. Curr Pharm Des. 2012;18:3624–44.; 39. Samaras K, Makkar S, Crawford JD, Kochan NA, Wen W, et al. Metformin use is associated with slowed cognitive decline and reduced incident dementia in older adults with type 2 diabetes: the Sydney Memory and Ageing Study. Diabetes Care. 2020;43:2691–701.; 40. Soraya H, Clanachan AS, Rameshrad M, Maleki-Dizaji N, Ghazi-Khansari M, Garjani A. Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction. Eur J Pharmacol. 2014;737:77–84.; 41. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP. Diabetes impairs hippocampal function through glucocorticoid-mediated efects on new and mature neurons. Nat Neurosci. 2008;11:309–17.; 42. Vinuesa A, Bentivegna M, Calfa G, Filipello F, Pomilio C, et al. Early exposure to a high-fat diet impacts on hippocampal plasticity: implication of microglia-derived exosome-like extracellular vesicles. Mol Neurobiol. 2019;56:5075–94.; 43. Wang YW, He SJ, Feng X, Cheng J, Luo YT, et al. Metformin: a review of its potential indications. Drug Des Dev Ther. 2017;11:2421–9.; 44. White MD, Angiolini JF, Alvarez YD, Kaur G, Zhao ZW, et al. Long-lived binding of Sox2 to DNA predicts cell fate in the four-cell mouse embryo. Cell. 2016;165:75–87.; 45. Yuan SY, Liu J, Zhou J, Lu W, Zhou HY, et al. AMPK mediates glucocorticoids stress-induced downregulation of the glucocorticoid receptor in cultured rat prefrontal cortical astrocytes. PloS one. 2016;11:e0159513.; 1805; 1791; 44; Pomilio, C., Pérez, N.G., Calandri, I. et al. Diabetic patients treated with metformin during early stages of Alzheimer’s disease show a better integral performance: data from ADNI study. GeroScience 44, 1791–1805 (2022). https://doi-org.ezproxy.cuc.edu.co/10.1007/s11357-022-00568-6Test; https://hdl.handle.net/11323/10907Test; Corporación Universidad de la Costa; REDICUC - Repositorio CUC; https://repositorio.cuc.edu.coTest

الإتاحة: https://doi.org/10.1007/s11357-022-00568-6Test
https://hdl.handle.net/11323/10907Test
https://repositorio.cuc.edu.coTest

View record in BASE

النص الكامل

تنقيح النتائج